Medical Innovation Exchange

Targeting Novo Nordisk in China's obesity market with a unique proposition, LeaderMed eyes US IPO

https://www.fiercebiotech.com/biotech/targeting-novo-nordisk-chinas-obesity-market-unique-proposition-leadermed-eyes-us-ipo

Leave a Comment

Your email address will not be published.

Leave the field below empty!